The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.

By C. Bommer, E. Heesemann, Vera Sagalova, J. Manne‐Goehler, Rifat A. Atun, T. Bärnighausen, Sandra Jeanne Vollmer. The Lancet Diabetes and Endocrinology, 2017

680 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Organizational Behavior and Human Resource Management

View Paper: https://www.semanticscholar.org/paper/44e73a4ee4c5b318dfb2f7382c53585d278155c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Amirhossein Sahebkar
2. Habib Yaribeygi

Citations in the corpus

• Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes (2019, background): “The global economic burden of diabetes in adults aged between 20 and 79 years was estimated to be US $1.31 trillion (95% CI 1.28-1.36) in 2015 [2].”
• Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 (2018, methodology): “A further important innovation is our use of cost ratios and labor market effect assumptions derived from studies conducted in both HICs and LMICs, whereas previous global projections only relied on estimates from HICs (14,22).”
• Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus (2020, background): “Diabetic complications result in considerable morbidity and mortality leading to major healthcare delivery costs [4].”